Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
ISELIN, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United...
Webcast replay of fireside chat now available ISELIN, N.J., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory...
Topline results from NORSE EIGHT expected in Q4 CY2024 ISELIN, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved...
ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United...
Received European Union (EU) and United Kingdom (UK) Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the treatment of wet AMDNORSE EIGHT current enrollment pace supports topline...
ISELIN, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on development and commercialization of ONS-5010/LYTENAVA™...
ISELIN, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that has achieved regulatory approval in the EU and UK for the first...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.6 | -9.11854103343 | 6.58 | 6.79 | 5.83 | 328864 | 6.08523001 | CS |
4 | -1.21 | -16.8289290682 | 7.19 | 8.32 | 5.83 | 243505 | 6.84470548 | CS |
12 | -1.52 | -20.2666666667 | 7.5 | 9.25 | 5.83 | 212046 | 7.44306229 | CS |
26 | -1.22 | -16.9444444444 | 7.2 | 12.8499 | 5.83 | 443028 | 8.36499507 | CS |
52 | 1.48 | 32.8888888889 | 4.5 | 18 | 4.092 | 2547860 | 9.20780561 | CS |
156 | -40.22 | -87.0562770563 | 46.2 | 48 | 4.004 | 1858662 | 15.35328866 | CS |
260 | -27.22 | -81.9879518072 | 33.2 | 85.2 | 4.004 | 1887152 | 23.52557582 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.